LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 119

Search options

  1. Article ; Online: Interaction between fatty acid oxidation and ethanol metabolism in liver.

    Lu, Yongke / George, Joseph

    American journal of physiology. Gastrointestinal and liver physiology

    2024  Volume 326, Issue 5, Page(s) G483–G494

    Abstract: Fatty acid oxidation (FAO) releases the energy stored in fat to maintain basic biological processes. Dehydrogenation is a major way to oxidize fatty acids, which needs ... ...

    Abstract Fatty acid oxidation (FAO) releases the energy stored in fat to maintain basic biological processes. Dehydrogenation is a major way to oxidize fatty acids, which needs NAD
    MeSH term(s) Humans ; Catalase ; NAD ; Cytochrome P-450 CYP2E1 ; Hydrogen Peroxide ; Fatty Liver ; Ethanol ; Liver Diseases, Alcoholic ; Fatty Acids
    Chemical Substances Catalase (EC 1.11.1.6) ; NAD (0U46U6E8UK) ; Cytochrome P-450 CYP2E1 (EC 1.14.13.-) ; Hydrogen Peroxide (BBX060AN9V) ; Ethanol (3K9958V90M) ; Fatty Acids
    Language English
    Publishing date 2024-03-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 603840-2
    ISSN 1522-1547 ; 0193-1857
    ISSN (online) 1522-1547
    ISSN 0193-1857
    DOI 10.1152/ajpgi.00281.2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARα-mediated regulation of adipose tissue mass.

    Xu, Yunhui / Lu, Yongke

    Biochemical and biophysical research communications

    2022  Volume 619, Page(s) 84–89

    Abstract: Fibroblast growth factor 21 (FGF21) is regulated by peroxisome proliferator activated receptor α (PPARα) in the liver. FGF21 regulates lipid metabolism via fibroblast growth factor receptor 1 (FGFR1). FGF21 protect against alcoholic fatty liver (AFL), ... ...

    Abstract Fibroblast growth factor 21 (FGF21) is regulated by peroxisome proliferator activated receptor α (PPARα) in the liver. FGF21 regulates lipid metabolism via fibroblast growth factor receptor 1 (FGFR1). FGF21 protect against alcoholic fatty liver (AFL), however, FGF21 does not exert protective effect through liver FGFR1. We have previously shown that PPARα agonist WY-14,643 induces FGF21 and adipose atrophy but fails to protect against chronic ethanol-induced AFL in mice lacking adipose FGFR1. In this study we tested the direct role of the FGF21 in regulation of adipose tissue mass and ethanol induced-hepatic triglyceride (TG) accumulation in normal control (fgfr1
    MeSH term(s) Adipose Tissue/metabolism ; Animals ; Atrophy ; Ethanol/pharmacology ; Fatty Liver, Alcoholic/metabolism ; Fibroblast Growth Factors/metabolism ; Liver/metabolism ; Mice ; Mice, Knockout ; PPAR alpha/metabolism ; Receptor, Fibroblast Growth Factor, Type 1/genetics ; Receptor, Fibroblast Growth Factor, Type 1/metabolism
    Chemical Substances PPAR alpha ; fibroblast growth factor 21 ; Ethanol (3K9958V90M) ; Fibroblast Growth Factors (62031-54-3) ; Receptor, Fibroblast Growth Factor, Type 1 (EC 2.7.10.1)
    Language English
    Publishing date 2022-06-11
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2022.05.099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARα-mediated regulation of adipose tissue mass

    Xu, Yunhui / Lu, Yongke

    Biochemical and biophysical research communications. 2022 Sept. 03, v. 619

    2022  

    Abstract: Fibroblast growth factor 21 (FGF21) is regulated by peroxisome proliferator activated receptor α (PPARα) in the liver. FGF21 regulates lipid metabolism via fibroblast growth factor receptor 1 (FGFR1). FGF21 protect against alcoholic fatty liver (AFL), ... ...

    Abstract Fibroblast growth factor 21 (FGF21) is regulated by peroxisome proliferator activated receptor α (PPARα) in the liver. FGF21 regulates lipid metabolism via fibroblast growth factor receptor 1 (FGFR1). FGF21 protect against alcoholic fatty liver (AFL), however, FGF21 does not exert protective effect through liver FGFR1. We have previously shown that PPARα agonist WY-14,643 induces FGF21 and adipose atrophy but fails to protect against chronic ethanol-induced AFL in mice lacking adipose FGFR1. In this study we tested the direct role of the FGF21 in regulation of adipose tissue mass and ethanol induced-hepatic triglyceride (TG) accumulation in normal control (fgfr1ᶠˡ/ᶠˡ) mice and in adipose FGFR1 knockout mice (fgfr1ᵃᵈⁱᵖᵒQ⁻ᶜʳᵉ). First, we tested whether WY-14,643 effects on adipose atrophy and AFL can be recapitulated in binge alcohol model. As in chronic model, adipose tissue mass and serum free fatty acid (FFA) were decreased by WY-14,643 in the fgfr1ᵃᵈⁱᵖᵒQ⁻ᶜʳᵉ mice but not in the fgfr1ᶠˡ/ᶠˡ mice. However, in contrast to the chronic model, binge ethanol-induced AFL was blunted by WY-14,643 to a greater extent in the fgfr1ᵃᵈⁱᵖᵒQ⁻ᶜʳᵉ mice than in the fgfr1ᶠˡ/ᶠˡ mice. Similarly, circulating FGF21 was elevated by binge ethanol to a greater extent in the fgfr1ᵃᵈⁱᵖᵒQ⁻ᶜʳᵉ mice than in the fgfr1ᶠˡ/ᶠˡ mice on top of WY-14,643 treatment. Accordingly, we tested the involvement of the FGF21 in adipose atrophy and AFL. Consistent with FGFR1-dependent effects of WY-14,643 on adipose atrophy and AFL, recombinant mouse FGF21 (rFGF21) injection induced adipose atrophy, blunted AFL and serum TG elevation to a greater extent in the fgfr1ᵃᵈⁱᵖᵒQ⁻ᶜʳᵉ mice than in the fgfr1ᶠˡ/ᶠˡ mice. These results indicated the consistency of adipose FGFR1 dependent effect of WY-14,643 and FGF21 in PPARα-mediated regulation of adipose tissue mass and fat mobilization from adipose tissues to the liver, suggesting that adipose tissues crosstalk with liver through an interaction between liver PPARα-FGF21 and adipose FGFR1 to maintain adipose tissue mass.
    Keywords adipose tissue ; agonists ; atrophy ; blood serum ; ethanol ; fatty liver ; fibroblast growth factor receptor 1 ; fibroblast growth factors ; free fatty acids ; lipid metabolism ; liver ; mice ; models ; protective effect ; research ; triacylglycerols
    Language English
    Dates of publication 2022-0903
    Size p. 84-89.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 205723-2
    ISSN 0006-291X ; 0006-291X
    ISSN (online) 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2022.05.099
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.

    Xu, Yunhui / Denning, Krista L / Lu, Yongke

    Biochemical and biophysical research communications

    2022  Volume 613, Page(s) 47–52

    Abstract: Peroxisome proliferator-activated receptor α (PPARα) regulates fatty acid oxidation (FAO). Usually, very-long chain fatty acids are first activated by acyl-CoA synthetase (ACS) to generate acyl-CoA for oxidation by acyl-CoA oxidase (ACOX) in peroxisomes, ...

    Abstract Peroxisome proliferator-activated receptor α (PPARα) regulates fatty acid oxidation (FAO). Usually, very-long chain fatty acids are first activated by acyl-CoA synthetase (ACS) to generate acyl-CoA for oxidation by acyl-CoA oxidase (ACOX) in peroxisomes, and the resultant shorter chain fatty acids will be further oxidized in mitochondria. ACS long-chain family member 4 (ACSL4) preferentially uses arachidonic acid (AA) as substrates to synthesize arachidonoyl-CoA. Arachidonoyl-CoA is usually esterified into phospholipids. When AA is released by phospholipase A2 (PLA2) from phospholipids, it will be used for prostaglandin synthesis by cyclooxygenases (COX). In this study, when PPARα agonist WY-14,643 was mixed in liquid Lieber-DeCarli ethanol or control diets and fed to mice, liver PLA2, COX-2, and ACOX1 were induced but ACSL4 was inhibited, suggesting that AA released by PLA2 from phospholipid will be metabolized to prostaglandin via COX-2 instead of being synthesized into acyl-CoA by ACSL4. However, liver prostaglandin E2 (PGE2), a major component of prostaglandin, was not increased with the induced COX-2 but decreased by WY-14,643. ACOX1 specific inhibitor mixed in the liquid diets restored both the WY-14,643-suppressed liver TG and PGE2, but COX-2 specific inhibitor celecoxib mixed in the liquid diets reversed the WY-14,643-suppressed liver TG but not liver PGE2 contents. These results suggest that induction of PLA2, COX-2 and ACOX1 orchestrates to increase oxidation of AA/PGE2, which constitutes one new mechanism by which PPARα induces peroxisomal FAO and inhibits ethanol-induced liver fat accumulation.
    MeSH term(s) Acyl-CoA Oxidase/metabolism ; Animals ; Coenzyme A/metabolism ; Cyclooxygenase 2/metabolism ; Dinoprostone/metabolism ; Fatty Acids/metabolism ; Fatty Liver, Alcoholic/drug therapy ; Fatty Liver, Alcoholic/metabolism ; Lipid Metabolism/drug effects ; Liver/metabolism ; Mice ; PPAR alpha/agonists ; PPAR alpha/metabolism ; Peroxisomes/drug effects ; Peroxisomes/metabolism ; Phospholipases A2/metabolism ; Phospholipids/metabolism ; Pyrimidines/pharmacology ; Signal Transduction/drug effects
    Chemical Substances Fatty Acids ; PPAR alpha ; Phospholipids ; Pyrimidines ; pirinixic acid (86C4MRT55A) ; Ptgs2 protein, mouse (EC 1.14.99.-) ; Cyclooxygenase 2 (EC 1.14.99.1) ; ACOX1 protein, mouse (EC 1.3.3.6) ; Acyl-CoA Oxidase (EC 1.3.3.6) ; Phospholipases A2 (EC 3.1.1.4) ; Dinoprostone (K7Q1JQR04M) ; Coenzyme A (SAA04E81UX)
    Language English
    Publishing date 2022-04-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 205723-2
    ISSN 1090-2104 ; 0006-291X ; 0006-291X
    ISSN (online) 1090-2104 ; 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2022.04.132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: fosA11

    Lu, Wei / Zhou, Shihan / Ma, Xueli / Xu, Nuo / Liu, Dongxin / Zhang, Keqing / Zheng, Yongke / Wu, Shenghai

    Microbiology spectrum

    2023  Volume 12, Issue 2, Page(s) e0254223

    Abstract: This study investigated resistance genes corresponding to the fosfomycin resistance phenotype in clinical ... ...

    Abstract This study investigated resistance genes corresponding to the fosfomycin resistance phenotype in clinical isolate
    MeSH term(s) Fosfomycin/pharmacology ; Providencia/genetics ; Anti-Bacterial Agents/pharmacology ; Escherichia coli/genetics ; Microbial Sensitivity Tests ; Chromosomes
    Chemical Substances Fosfomycin (2N81MY12TE) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-12-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2807133-5
    ISSN 2165-0497 ; 2165-0497
    ISSN (online) 2165-0497
    ISSN 2165-0497
    DOI 10.1128/spectrum.02542-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Under peroxisome proliferation acyl-CoA oxidase coordinates with catalase to enhance ethanol metabolism.

    Chen, Xue / Denning, Krista L / Mazur, Anna / Lawrence, Logan M / Wang, Xiaodong / Lu, Yongke

    Free radical biology & medicine

    2023  Volume 208, Page(s) 221–228

    Abstract: In peroxisomes, acyl-CoA oxidase (ACOX) oxidizes fatty acids and produces ... ...

    Abstract In peroxisomes, acyl-CoA oxidase (ACOX) oxidizes fatty acids and produces H
    MeSH term(s) Animals ; Mice ; Acyl-CoA Oxidase/genetics ; Acyl-CoA Oxidase/metabolism ; Catalase/genetics ; Catalase/metabolism ; Cell Proliferation ; Ethanol/metabolism ; Fatty Liver/metabolism ; Hydrogen Peroxide/metabolism ; Liver/metabolism ; Mice, Knockout ; NF-E2-Related Factor 2/genetics ; NF-E2-Related Factor 2/metabolism ; Peroxisomes/metabolism ; PPAR alpha/genetics ; PPAR alpha/metabolism
    Chemical Substances Acyl-CoA Oxidase (EC 1.3.3.6) ; Catalase (EC 1.11.1.6) ; Ethanol (3K9958V90M) ; Hydrogen Peroxide (BBX060AN9V) ; NF-E2-Related Factor 2 ; PPAR alpha ; pirinixic acid (86C4MRT55A)
    Language English
    Publishing date 2023-08-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 807032-5
    ISSN 1873-4596 ; 0891-5849
    ISSN (online) 1873-4596
    ISSN 0891-5849
    DOI 10.1016/j.freeradbiomed.2023.08.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Dynamic Data Augmentation Based on Imitating Real Scene for Lane Line Detection

    Qingwang Wang / Lu Wang / Yongke Chi / Tao Shen / Jian Song / Ju Gao / Shiquan Shen

    Remote Sensing, Vol 15, Iss 1212, p

    2023  Volume 1212

    Abstract: With the rapid development of urban ground transportation, lane line detection is gradually becoming a major technological direction to help to realize safe vehicle navigation. However, lane line detection results may have incompleteness issues, such as ... ...

    Abstract With the rapid development of urban ground transportation, lane line detection is gradually becoming a major technological direction to help to realize safe vehicle navigation. However, lane line detection results may have incompleteness issues, such as blurry lane lines and disappearance of the lane lines in the distance, since the lane lines may be heavily obscured by vehicles and pedestrians on the road. In addition, low-visibility environments also pose a challenge for lane line detection. To solve the above problems, we propose a dynamic data augmentation framework based on imitating real scenes (DDA-IRS). DDA-IRS contains three data augmentation strategies that simulate different realistic scenes (i.e., shadows, dazzle, and crowded). In this way, we expand from a limited scene dataset to realistically fit multiple complex scenes. Importantly, DDA-IRS is a lightweight framework that can be integrated with a variety of training-based models without modifying the original model. We evaluate the proposed DDA-IRS on the CULane dataset, and the results show that the data-enhanced model outperforms the baseline model by 0.5% in terms of F-measure. In particular, the F-measure of the “Normal”, “Crowded”, “Shadow”, “Arrow”, and “Curve” achieve a 0.4%, 0.1%, 1.6%, 0.4%, and 1.4% improvement, respectively.
    Keywords dynamic data augmentation ; imitating real scene ; lane line detection ; vehicle navigation ; urban ground transportation ; Science ; Q
    Language English
    Publishing date 2023-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Genome-wide DNA methylation analysis in schizophrenia with tardive dyskinesia: a preliminary study.

    Zhang, Ping / Lu, Yongke / Li, Yanli / Wang, Kesheng / An, Huimei / Tan, Yunlong

    Genes & genomics

    2023  Volume 45, Issue 10, Page(s) 1317–1328

    Abstract: Background: Tardive dyskinesia (TD) develops in 20-30% of schizophrenia patients and up to 50% in patients > 50 years old. DNA methylation may play an important role in the development of TD.: Objective: DNA methylation analyses in schizophrenia with ...

    Abstract Background: Tardive dyskinesia (TD) develops in 20-30% of schizophrenia patients and up to 50% in patients > 50 years old. DNA methylation may play an important role in the development of TD.
    Objective: DNA methylation analyses in schizophrenia with TD.
    Methods: We conducted a genome-wide DNA methylation analysis in schizophrenia with TD using methylated DNA immunoprecipitation coupled with next-generation sequencing (MeDIP-Seq) in a Chinese sample including five schizophrenia patients with TD and five without TD (NTD), and five healthy controls. The results were expressed as the log
    Results: Through genome-wide MeDIP-Seq analysis, we identified 116 genes that were significantly differentially methylated in promotor regions in comparison of TD group with NTD group including 66 hypermethylated genes (top 4 genes are GABRR1, VANGL2, ZNF534, and ZNF746) and 50 hypomethylated genes (top 4 genes are DERL3, GSTA4, KNCN, and LRRK1). Part of these genes (such as DERL3, DLGAP2, GABRR1, KLRG2, LRRK1, VANGL2, and ZP3) were previously reported to be associated with methylation in schizophrenia. Gene Ontology enrichment and KEGG pathway analyses identified several pathways. So far, we have confirmed the methylation of 3 genes (ARMC6, WDR75, and ZP3) in schizophrenia with TD using pyrosequencing.
    Conclusions: This study identified number of methylated genes and pathways for TD and will provide potential biomarkers for TD and serve as a resource for replication in other populations.
    MeSH term(s) Humans ; Middle Aged ; Tardive Dyskinesia/genetics ; DNA Methylation/genetics ; Schizophrenia/genetics ; Genome ; DNA/genetics ; Repressor Proteins/genetics
    Chemical Substances DNA (9007-49-2) ; ZNF746 protein, human ; Repressor Proteins
    Language English
    Publishing date 2023-07-06
    Publishing country Korea (South)
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2504587-8
    ISSN 2092-9293 ; 1976-9571
    ISSN (online) 2092-9293
    ISSN 1976-9571
    DOI 10.1007/s13258-023-01414-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice

    Xu, Yunhui / Denning, Krista L. / Lu, Yongke

    Biochemical and biophysical research communications. 2022 July 12, v. 613

    2022  

    Abstract: Peroxisome proliferator-activated receptor α (PPARα) regulates fatty acid oxidation (FAO). Usually, very-long chain fatty acids are first activated by acyl-CoA synthetase (ACS) to generate acyl-CoA for oxidation by acyl-CoA oxidase (ACOX) in peroxisomes, ...

    Abstract Peroxisome proliferator-activated receptor α (PPARα) regulates fatty acid oxidation (FAO). Usually, very-long chain fatty acids are first activated by acyl-CoA synthetase (ACS) to generate acyl-CoA for oxidation by acyl-CoA oxidase (ACOX) in peroxisomes, and the resultant shorter chain fatty acids will be further oxidized in mitochondria. ACS long-chain family member 4 (ACSL4) preferentially uses arachidonic acid (AA) as substrates to synthesize arachidonoyl-CoA. Arachidonoyl-CoA is usually esterified into phospholipids. When AA is released by phospholipase A2 (PLA2) from phospholipids, it will be used for prostaglandin synthesis by cyclooxygenases (COX). In this study, when PPARα agonist WY-14,643 was mixed in liquid Lieber-DeCarli ethanol or control diets and fed to mice, liver PLA2, COX-2, and ACOX1 were induced but ACSL4 was inhibited, suggesting that AA released by PLA2 from phospholipid will be metabolized to prostaglandin via COX-2 instead of being synthesized into acyl-CoA by ACSL4. However, liver prostaglandin E2 (PGE2), a major component of prostaglandin, was not increased with the induced COX-2 but decreased by WY-14,643. ACOX1 specific inhibitor mixed in the liquid diets restored both the WY-14,643-suppressed liver TG and PGE2, but COX-2 specific inhibitor celecoxib mixed in the liquid diets reversed the WY-14,643-suppressed liver TG but not liver PGE2 contents. These results suggest that induction of PLA2, COX-2 and ACOX1 orchestrates to increase oxidation of AA/PGE2, which constitutes one new mechanism by which PPARα induces peroxisomal FAO and inhibits ethanol-induced liver fat accumulation.
    Keywords acyl coenzyme A ; acyl-CoA oxidase ; agonists ; arachidonic acid ; beta oxidation ; esterification ; ethanol ; fatty liver ; liquids ; liver ; long-chain-fatty-acid-CoA ligase ; mitochondria ; oxidation ; peroxisomes ; phospholipase A2 ; phospholipids ; prostaglandin synthase ; prostaglandins ; research
    Language English
    Dates of publication 2022-0712
    Size p. 47-52.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 205723-2
    ISSN 0006-291X ; 0006-291X
    ISSN (online) 0006-291X
    ISSN 0006-291X
    DOI 10.1016/j.bbrc.2022.04.132
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: PPARα agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1.

    Xu, Yunhui / Denning, Krista L / Lu, Yongke

    Biochemical pharmacology

    2021  Volume 192, Page(s) 114678

    Abstract: Fibroblast growth factor 21 (FGF21) is mainly regulated by peroxisome proliferator-activated receptor α (PPARα) in liver. The PPARα-FGF21 axis protects against alcohol-related liver disease (ALD). FGF21 exerts its effect via FGF receptor 1 (FGFR1). ... ...

    Abstract Fibroblast growth factor 21 (FGF21) is mainly regulated by peroxisome proliferator-activated receptor α (PPARα) in liver. The PPARα-FGF21 axis protects against alcohol-related liver disease (ALD). FGF21 exerts its effect via FGF receptor 1 (FGFR1). However, liver specific FGFR1 abrogation had no effect on ALD. Adipose tissues highly express FGFR1. When adipocyte specific FGFR1 knockout (fgfr1
    MeSH term(s) Adipose Tissue/drug effects ; Adipose Tissue/metabolism ; Animals ; Atrophy/chemically induced ; Atrophy/metabolism ; Ethanol/administration & dosage ; Ethanol/toxicity ; Fatty Liver, Alcoholic/metabolism ; Fatty Liver, Alcoholic/prevention & control ; Female ; Mice ; Mice, Knockout ; PPAR alpha/agonists ; PPAR alpha/metabolism ; Peroxisome Proliferators/therapeutic use ; Peroxisome Proliferators/toxicity ; Pyrimidines/therapeutic use ; Pyrimidines/toxicity ; Receptor, Fibroblast Growth Factor, Type 1/deficiency ; Receptor, Fibroblast Growth Factor, Type 1/genetics
    Chemical Substances PPAR alpha ; Peroxisome Proliferators ; Pyrimidines ; Ethanol (3K9958V90M) ; pirinixic acid (86C4MRT55A) ; Fgfr1 protein, mouse (EC 2.7.10.1) ; Receptor, Fibroblast Growth Factor, Type 1 (EC 2.7.10.1)
    Language English
    Publishing date 2021-07-13
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 208787-x
    ISSN 1873-2968 ; 0006-2952
    ISSN (online) 1873-2968
    ISSN 0006-2952
    DOI 10.1016/j.bcp.2021.114678
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top